Literature DB >> 14638591

Long-term course of schizophrenic illness: Bleuler's study reconsidered.

Jiri Modestin1, Andreas Huber, Engin Satirli, Tina Malti, Daniel Hell.   

Abstract

OBJECTIVE: The influential 1972 study by Manfred Bleuler on the long-term course of schizophrenic illness has been reconsidered. The authors tested the diagnosis of schizophrenia in all patients and investigated how the distribution of the types of illness course and outcome would change after exclusion of patients whose diagnosis of schizophrenia could not be confirmed by modern diagnostic standards.
METHOD: Clinical charts and Bleuler's research notes on the original sample were assessed, and all patients were rediagnosed with the help of DSM-IV, DSM-III-R, ICD-10, the Research Diagnostic Criteria (RDC), Schneider's criteria, and an operationalized version of the criteria of Eugen Bleuler.
RESULTS: The diagnosis of schizophrenia was not confirmed in about 30% of the sample; the majority of these patients were rediagnosed with schizoaffective disorder. High diagnostic agreement was found between DSM-IV, DSM-III-R, ICD-10, and RDC; there was much less agreement with Bleuler's and Schneider's criteria. After exclusion of patients whose schizophrenia diagnosis was not confirmed, the proportion of patients with undulating course and recovery slightly decreased, and the proportion of patients with severe end state slightly increased. Nevertheless, the distribution of the types of long-term course did not significantly change, and even among patients with strictly defined schizophrenia, half had an undulating course with remissions and 12%-15% recovered.
CONCLUSIONS: Schizophrenic illness remains heterogeneous with regard to illness course and outcome even when narrowly diagnosed with the help of modern operationalized diagnostic criteria. Contemporary differentiation between schizophrenic and schizoaffective disorders is prognostically valid.

Entities:  

Mesh:

Year:  2003        PMID: 14638591     DOI: 10.1176/appi.ajp.160.12.2202

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  15 in total

Review 1.  First rank symptoms for schizophrenia.

Authors:  Karla Soares-Weiser; Nicola Maayan; Hanna Bergman; Clare Davenport; Amanda J Kirkham; Sarah Grabowski; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-01-25

Review 2.  Diagnosing schizophrenia circa 2005: how and why?

Authors:  Laurie M McCormick; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

3.  Associative hallucinations result from stimulating left ventromedial temporal cortex.

Authors:  Elissa M Aminoff; Yuanning Li; John A Pyles; Michael J Ward; R Mark Richardson; Avniel S Ghuman
Journal:  Cortex       Date:  2016-07-26       Impact factor: 4.027

4.  Mental disorder and long-term risk of mortality: 41 years of follow-up of a population sample in Stockholm, Sweden.

Authors:  A Lundin; K Modig; J Halldin; A C Carlsson; P Wändell; H Theobald
Journal:  Epidemiol Psychiatr Sci       Date:  2015-06-01       Impact factor: 6.892

Review 5.  Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?

Authors:  Lennart B Jansson; Josef Parnas
Journal:  Schizophr Bull       Date:  2006-12-08       Impact factor: 9.306

6.  The course and outcomes of episodic endogenous psychoses with juvenile onset (a follow-up study).

Authors:  V G Kaleda
Journal:  Neurosci Behav Physiol       Date:  2009-11

Review 7.  Toward defining schizophrenia as a more useful clinical concept.

Authors:  Jess G Fiedorowicz; Eric A Epping; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

8.  Recovery and Recovering in Older Adults with Schizophrenia: A 5-Tier Model.

Authors:  Carl I Cohen; Michael M Reinhardt
Journal:  Am J Geriatr Psychiatry       Date:  2020-04-02       Impact factor: 4.105

9.  Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study.

Authors:  C Morgan; J Lappin; M Heslin; K Donoghue; B Lomas; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; G A Doody; P Dazzan
Journal:  Psychol Med       Date:  2014-02-26       Impact factor: 7.723

10.  Dorsolateral prefrontal lobe volume and neurological soft signs as predictors of clinical social and functional outcome in schizophrenia: A longitudinal study.

Authors:  Rishikesh V Behere
Journal:  Indian J Psychiatry       Date:  2013-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.